News
NEWS: "Hot Off the Press"
- ZenaTech Closes a Seventh Drone as a Service (DaaS) Acquisition in North Carolina Expanding its Southeast Region and Government Opportunities
- The Role of Drones in Public Safety
- ZenaTech’s ZenaDrone Initiates AUVSI Membership Upgrade, Enabling Leadership on Drone Policy and Strengthening US Defense and Government Engagement
- Responding to the White House AI Action Plan, ZenaTech’s ZenaDrone Launches Zena AI, Inc., a Specialized AI Development Center for US Defense and Homeland Security Applications
- Alpha Modus Holdings Inc. (NASDAQ: AMOD) Eliminates Variable Rate Debt and Finalizes Capital Structure Cleanup
- ZenaTech’s ZenaDrone Partners with Eagle Point Funding to Win US Defense Customers
- Alpha Modus (NASDAQ: AMOD) Secures Exclusive National Rights to Deploy CashXAI’s AI-Driven Financial Kiosks-Aimed to Serve 60M+ Underbanked in America
- Alpha Modus (NASDAQ: AMOD) Secures Exclusive National Rights to Deploy CashXAI’s AI-Driven Financial Kiosks-Aimed to Serve 60M+ Underbanked in America
- AI Chatbots: A Transformative Market Set to Soar Beyond 2026
- Alpha Modus CEO Family Commits Initial $1.5M in Strategic Financing (at $5 Fixed Strike Conversion Price) Strengthens Company’s Capital Position Ahead of Major Growth Initiatives
- Alpha Modus (NASDAQ: AMOD) Receives Confirmation of Listing Transfer to Nasdaq Capital Market, Confirms NASDAQ Compliance, Defends Capital Integrity, and Asserts Preservation of Once-in-a-Generation Asset
- Alpha Modus Awarded New U.S. Patent Strengthening Its AI Retail Technology Portfolio
- Alpha Modus (NASDAQ: AMOD) Expands CashX to African Specialty Retailers as Strategic Beachhead into Diaspora Markets
- Alpha Modus (NASDAQ: AMOD) Expands CashX to African Specialty Retailers as Strategic Beachhead into Diaspora Markets
- Alpha Modus Featured in 2nd International Business Times Story
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Alpha Modus Ventures Files Federal Lawsuit Against Rackspace for Infringement of Foundational Fibre Channel over Ethernet Patents
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by New to The Street TV.
- RMX (Reticulate Micro) Secures GSA Schedule Placement, Enhancing Government Market Access
- Genprex Signs Exclusive License to Additional Gene Therapy Technology with UTHealth Houston for the Treatment of Glioblastoma
- Reticulate Micro’s VAST Platform to Power Advanced Tactical Video at SOF Week 2025
- Beverage Brands Are Moving From Flavor to Function and It's Paying Off for Investors
- IQSTEL Announces Strategic Decision to Uplist to NASDAQ and Executes Reverse Stock Split to Meet Minimum Listing Requirements
- iQSTEL Announces Reverse Stock Split in Preparation for Uplist to Nasdaq
- Top Penny Stocks To Watch In May 2025
- NIP Group Inc (NIPG) (Q4 2024) Earnings Call Highlights: Navigating Growth and Challenges in a ...
- Full Year 2024 NIP Group Inc Earnings Call
- Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Ras Inhibitor Resistant Lung Cancer at the 2025 AACR Annual Meeting
- NIP Group Inc. Reports Second Half and Full Year 2024 Unaudited Financial Results
- Cycurion, Inc. Announces $6 Million Contract Award by Major Municipal Transportation Agency
- Genprex Collaborators to Present Positive Preclinical Data on Diabetes Gene Therapy at the ASGCT 28th Annual Meeting
- Genprex Signs Exclusive Technology License Agreement with New York University Langone Health for the Treatment of Mesothelioma
- NIP Group to Report Unaudited Financial Results for the Second Half and Full Year 2024 on April 30, 2025
- Forget Sugary Sodas Wellness Drinks Are Gaining Ground With Consumers and Investors
- Ascent Solar Technologies Hosts Customer and Partner Discussions During Space Symposium
- Genprex Selected to Present Trial Design of Acclaim-3 Clinical Trial Evaluating Reqorsa® Gene Therapy in Small Cell Lung Cancer at 2025 ASCO Annual Meeting
- Reticulate Micro, Inc. Completes Acquisition of Remaining RMX Industries Inc. Shares, Consolidates Operations, and Expands Leadership Team
- Green Leaf Innovations Announces Q1 Corporate Update and Board Resolution
- Northann Corp. Receives NYSE Notice Regarding Late Filing of Annual Report on Form 10-K
- Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
- Opus Holdings Unveils Powerhouse Leadership Team to Drive Aggressive Growth and Transform Market Trajectory
- Cycurion, Inc. Announces Expansion into Latin America Through Partnership with LSV-TECH International of Colombia
- Genprex Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings
- Safety Shot, Inc. Postpones Record Date for Spin-Off and Distribution of Shares Common Stock of Caring Brands, Inc. - Updated
- Cycurion Reports Full Year 2024 Financial Results
- Green Leaf Innovations Reports Exponential Revenue Growth for 2024
- VSee Unveils Advanced Telenursing Robotics Solution Targeting 3-5% Reduction in Hospital Nursing Costs
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Cycurion Announces Reginald S. Bailey, Sr Joins Board of Directors
- Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine